Institutional investors purchased a net $25.9 thousand shares of TARO during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 11.03% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VALENTINE CAPITAL ASSET MANAGEME... Bought 133.2 Thousand shares of Taro Pharmaceutical Indus...